161 related articles for article (PubMed ID: 16620769)
1. Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.
Steele DS; Duke AM
Arch Biochem Biophys; 2007 Feb; 458(1):57-64. PubMed ID: 16620769
[TBL] [Abstract][Full Text] [Related]
2. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.
Diaz-Sylvester PL; Porta M; Copello JA
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228
[TBL] [Abstract][Full Text] [Related]
3. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia.
Duke AM; Hopkins PM; Halsall PJ; Steele DS
Br J Anaesth; 2006 Sep; 97(3):320-8. PubMed ID: 16849381
[TBL] [Abstract][Full Text] [Related]
4. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in rat skeletal muscle.
Duke AM; Hopkins PM; Steele DS
J Physiol; 2003 Sep; 551(Pt 2):447-54. PubMed ID: 12909676
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
Glover L; Heffron JJ; Ohlendieck K
J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
Wehner M; Rueffert H; Koenig F; Olthoff D
Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
[TBL] [Abstract][Full Text] [Related]
7. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
Duke AM; Hopkins PM; Halsal JP; Steele DS
Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
[TBL] [Abstract][Full Text] [Related]
8. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
[TBL] [Abstract][Full Text] [Related]
9. Divergent effects of the malignant hyperthermia-susceptible Arg(615)-->Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1.
Balog EM; Fruen BR; Shomer NH; Louis CF
Biophys J; 2001 Oct; 81(4):2050-8. PubMed ID: 11566777
[TBL] [Abstract][Full Text] [Related]
10. [High resolution fluorescence microscopy in combination with mathematical modelling. First evidence of sub-cellular anesthetic effects on Ca2+ sparks in situ].
Uttenweiler D; Both M; Zink W; Sinner B; Martin E; Graf BM; Fink RH
Anaesthesist; 2003 Feb; 52(2):162-8. PubMed ID: 12624702
[TBL] [Abstract][Full Text] [Related]
11. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
[TBL] [Abstract][Full Text] [Related]
12. Effect of gadolinium on the ryanodine receptor/sarcoplasmic reticulum calcium release channel of skeletal muscle.
Sárközi S; Szegedi C; Lukács B; Ronjat M; Jóna I
FEBS J; 2005 Jan; 272(2):464-71. PubMed ID: 15654884
[TBL] [Abstract][Full Text] [Related]
13. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
Feng W; Barrientos GC; Cherednichenko G; Yang T; Padilla IT; Truong K; Allen PD; Lopez JR; Pessah IN
Mol Pharmacol; 2011 Mar; 79(3):420-31. PubMed ID: 21156754
[TBL] [Abstract][Full Text] [Related]
14. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
[TBL] [Abstract][Full Text] [Related]
15. Calcium-induced calcium release in skeletal muscle.
Endo M
Physiol Rev; 2009 Oct; 89(4):1153-76. PubMed ID: 19789379
[TBL] [Abstract][Full Text] [Related]
16. Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.
Jiang D; Chen W; Xiao J; Wang R; Kong H; Jones PP; Zhang L; Fruen B; Chen SR
J Biol Chem; 2008 Jul; 283(30):20813-20. PubMed ID: 18505726
[TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
Gomez AC; Holford TW; Yamaguchi N
Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
[TBL] [Abstract][Full Text] [Related]
18. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia.
Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN
Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347
[TBL] [Abstract][Full Text] [Related]
19. Increasing the number of diagnostic mutations in malignant hyperthermia.
Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
[TBL] [Abstract][Full Text] [Related]
20. Novel ryanodine receptor mutation that may cause malignant hyperthermia.
Kaufmann A; Kraft B; Michalek-Sauberer A; Weigl LG
Anesthesiology; 2008 Sep; 109(3):457-64. PubMed ID: 18719443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
